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women with mild knee osteoarthritis: protocol for
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Background: Symptoms associated with osteoarthritis of the knee result in decreased function, loss of working
capacity and extensive social and medical costs. There is a need to investigate and develop effective interventions
to minimise the impact of and even prevent the progression of osteoarthritis. Aquatic exercise has been shown to
be effective at reducing the impact of osteoarthritis. The purpose of this article is to describe the rationale, design
and intervention of a study investigating the effect of an aquatic resistance exercise intervention on cartilage in
postmenopausal women with mild knee osteoarthritis.
Methods: A minimum of 80 volunteers who meet the inclusion criteria will be recruited from the local population
through newspaper advertisements. Following initial assessment volunteers will be randomised into two groups.
The intervention group will participate in a progressive aquatic resistance exercise program of 1-hour duration 3
times a week for four months. The control group will be asked to maintain normal care during this period. Primary
outcome measure for this study is the biochemical composition of knee cartilage measured using quantitative
magnetic resonance imaging; T2 relaxation time and delayed gadolinium-enhanced magnetic resonance imaging
techniques. In addition, knee cartilage morphology as regional cartilage thickness will be studied. Secondary
outcomes include measures of body composition and bone traits using dual energy x-ray absorptiometry and
peripheral quantitative computed tomography, pain, function using questionnaires and physical performance tests
and quality of life. Measurements will be performed at baseline, after the 4-month intervention period and at one
year follow up.
Discussion: This randomised controlled trial will investigate the effect a progressive aquatic resistance exercise
program has on the biochemical composition of cartilage in post-menopausal women with mild knee
osteoarthritis. This is the first study to investigate what impact aquatic exercise has on human articular cartilage. In
addition it will investigate the effect aquatic exercise has on physical function, pain, bone and body composition
and quality of life. The results of this study will help optimise the prescription of aquatic exercise to persons with
mild knee osteoarthritis.
Trial registration: ISRCTN65346593.
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Osteoarthritis (OA) of the lower limb is a leading cause
of decreased function and quality of life [1]. It has been
estimated that the prevalence of symptomatic OA of the
knee is between 7-33% with an increase in prevalence
with age and is the most common site of symptomatic
OA [2-6]. Early signs of OA in articular cartilage, which
is constituent for the initiation and progression of OA,
are characterised with loss of proteoglycans, breakdown
of the collagen matrix and increased water content [7].
As the disease progresses there is fibrillation of the car-
tilage, changes in the subchondral bone, formation of
osteophytes and thickening of the synovium [8-11] and
as such OA is considered a whole joint disease. These
modifications within the joint lead to the gradual devel-
opment of clinical symptoms such as stiffness, decreased
range of motion and pain [12] which cause a decrease in
joint proprioception [13] and inhibits muscle activation
[14,15] leading to a decrease in activity. This disuse re-
sults in a lowering of aerobic capacity, muscle strength
and muscle mass and ultimately a decrease in functional
capacity and increased dependence [16,17]. Additionally,
reduced muscle strength is a risk factor for future pain
[17], self-reported knee instability [18] and increased risk
of falling [19]. These in combination cause the extensive
social and medical costs to society as a direct or indirect
result of OA.
Although there is no known cure for OA the disease-
related factors such as impaired muscle function and re-
duced aerobic fitness can be improved and maintained
with therapeutic exercise [20,21]. Previous systematic re-
views have demonstrated that exercise has positive ef-
fects on pain and function for people with symptomatic
OA of the knee [21-23] and is recommended as one of
the primary non-pharmaceutical treatment modalities in
current OA guidelines [24-29]. Exercising in water is
also strongly recommended in these guidelines. There is
evidence to suggest that therapeutic aquatic exercise has
a short term positive effect on pain and function in per-
sons with OA of knee and/or hip similar to that of land
training [30,31]. There is good evidence to support the
use of strength exercises in the management of symp-
toms resulting from OA [32] however, there is
conflicting evidence that therapeutic aquatic exercises
can improve strength of lower limb muscles in persons
with OA [33-40]. It is thought that the benefits from
aquatic exercise are primarily a result of the decreased
effects of gravity. Buoyancy reduces compressive and
shear forces on joints and thus offers a comfortable
training medium for patients with OA [41].
Previously, one restriction in OA research was the lack
of non-invasive in vivo techniques to quantify the struc-
ture and acute changes in cartilage. Advances in mag-
netic resonance imaging (MRI) have made mapping ofthe articular cartilage and loading related changes pos-
sible [42]. The “delayed Gadolinium Enhanced MRI of
Cartilage” (dGEMRIC) technique utilizes a paramagnetic
contrast agent gadolinium (Gd-DTPA2-) to detect early
reduction of glycosaminoglycan (GAG) from the matrix,
a phenomenon considered to represent the onset of the
degenerative process of cartilage [43]. Measurement of
T2 relaxation time, sensitive to degeneration of tissue
collagen and the orientation of collagen fibres in the
extracellular matrix, has been developed to detect early
degeneration or senescent changes of cartilage [44,45].
In addition, the assessment of morphological properties
from three-dimensional MRI measurements enables as-
sessment of tissue changes at a macroscopic scale [46]
which have been found to be reliable, responsive and
valid methods for mapping the volumetric data of articu-
lar cartilage [47-49].
There is still a lack of evidence that human cartilage
can adapt to mechanical loading in a similar way to
other tissues such as bone and muscle. Animal studies
have suggested that physical exercise can improve tissue
integrity by increasing the GAG content and indentation
stiffness in load bearing cartilage [50,51]. In a cross-
sectional study Tiderius et al. [52] concluded, based on
dGEMRIC measurements, that GAG content was higher
in regularly exercising individuals than in sedentary sub-
jects. Additionally, observations by Teichtahl et al. [53]
suggest that vigorous physical activity is associated with
a reduced rate of patella cartilage volume loss in asymp-
tomatic subjects. To date, only one randomised inter-
vention study investigating the direct effect of exercise
on biochemical composition of human cartilage [54] has
been published. Roos et al. [54] reported a positive effect
of a moderate four months exercise on the GAG con-
tent, measured with dGEMRIC in subjects with high risk
of knee OA. Another study by Cotofana et al. [55] pro-
vides no evidence that a 3-month exercise intervention
in untrained middle-aged women can significantly alter
cartilage morphology in the knee joint. Furthermore, the
optimal type or intensity of exercise for improvement in
cartilage is not known and longitudinal effects of train-
ing are needed to determine the exercise response once
OA is established. In particular, there are no studies in-
vestigating the effect non-impact training such as thera-
peutic aquatic exercise has on the structures related to
and progression of OA in the knee joint.
Therefore we plan to investigate the effects of an in-
tensive aquatic resistance exercise program on the bio-
chemical composition and morphology of the knee
cartilage as well as its effect on physical function in post-
menopausal women with mild knee osteoarthritis. In
addition, we plan to discover if the possible benefits of
exercise on cartilage, symptoms and physical function
can be maintained one year after training period.
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Figure 1 Flow chart showing enrolment, allocation and
follow-up measurements.
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design and intervention of a study investigating the ef-
fect an aquatic resistance exercise intervention has on
the cartilage in postmenopausal women with mild knee
osteoarthritis.
Methods and design
Study design
The design of this study will be a 4-month randomised
controlled exercise intervention study (RCT) with a 16 -
month follow up (Trial registration: ISRCTN65346593).
After baseline measurements the voluntary participants
will be randomly assigned into the two arms of the
study, an aquatic resistance strength training group and
a control group. All the outcome measurements will be
performed at baseline, after the 4-month intervention
and at follow up 12 months after cessation of training.
Participants and selection criteria
Volunteer postmenopausal women, between the ages of
60–68 year-old, will be recruited through a series of
local newspaper advertisements and will be gathered
from the county of Central Finland which has a popula-
tion of approximately 275 000. Inclusion eligibility, (see
below), will be initially assessed using a structured tele-
phone interview. The telephone questionnaire includes
questions concerning degree of knee pain, current level
of physical activity and past medical history.
Suitable participants will be taken forward and they
will undergo weight bearing x-ray imaging of both
knees. An experienced radiologist and orthopaedic
physician will assess the images grading the degree
of OA in the tibiofemoral and patellofemoral joints
using the Kellgren-Lawrence grading (K/L 0-IV) [56].
Those participants who have a KL score of I (possible
osteophytes) or II (definite osteophytes, possible joint
space narrowing), will be included in the next stage
of eligibility assessment and undergo a medical and
physiotherapy screening. At this point any possible
physical or medical limitations to full participation in
the intervention will be assessed e.g. severely restricted
joint range of movement (ROM), excessive laxity of
knee joint, possible physical disabilities and abnormal-
ities found from resting echocardiogram.
Subjects will be excluded if they have at least one of the
following criteria; BMI > 34, resting pain in knee VAS >
50/100, known loose particles in knee joint, acute inflam-
mation in knee joint, knee intra-articular steroid injection
in previous 3 months or oral steroid medication treatment
in the previous 12 months, undergoing treatment for
osteoporosis or T-score for femoral neck bone mineral
density (BMD, g/cm2) lower than −2.5 i.e. indicating
osteoporosis as measured with DXA [57-59], previous
cancer or radiotherapy, suffer from type I or II diabetes,cardiac disease, diagnosed rheumatic disease (other than
OA), undergone surgical procedure to knee (excluding
menisectomy or arthroscopy if over 12 months ago) or
joint replacement surgery in lower limbs.
Additional exclusion criteria are problems that would
prevent MRI imaging, including electronic or magnetic im-
plants e.g. pace maker, metal within body e.g. internal bone
fixations, artificial aortic heart valve, metal particles in eyes,
large tattoos on lower limb, claustrophobia or possible al-
lergy to the contrast medium. Further, fasting blood sam-
ples will be taken to analyse Krea to ensure kidney function
for normal removal of contrast medium from the body. All
those participants fulfilling all the inclusion criteria will be
included into the study and undergo the baseline measure-
ments. Figure 1 shows the flow chart describing the selec-
tion and measurement procedure for the whole study.
Sample size
The sample size and power calculations have been esti-
mated for the primary end points of this study, i.e. the
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et al. [54] and Tiderius et al. [55] it is estimated that 30
subjects are needed, at 80% power, to detect a mean ±
SD difference of 40 ± 40 msec in the dGEMRIC between
groups [54]. It is estimated that dropout rate will be
about 20% at the 16 months follow up, consequently at
least 70 subjects will need to be recruited.
Randomisation and blinding
The subjects will be randomly allocated into either of the
two arms of the study by an external statistician blinded
for the intervention and study participants and will only
be provided with a randomisation number for each par-
ticipant and severity of OA in knee according to x-ray
classification. A computer generated block randomisation
of size of ten, stratified according to Kellgren-Lawrence
grading 1 and 2, will be used to ensure equal distribution
of severity of OA within each group and equal group size.
As with all exercise intervention studies blinding of the
subject from the intervention is not possible. Researchers
(BW, MM, AH) will be blinded to the allocation of groups
as well as blinded from the interventions and measure-
ment except for pQCT (MM) and DXA (BW) measure-
ments. Due to practical limitations the physical therapists
providing the intervention will also be performing the
physical performance measurements. All statistical ana-
lyses will be completed by a statistician (HK), who is
blinded to the participants and measurements.
Primary outcomes
This research project will have two primary outcome
measures. Delayed gadolinium-enhance magnetic reson-
ance imaging of cartilage (dGEMRIC), sensitive to the
distribution of GAG, will be used to evaluate the
biochemical composition of cartilage. Arrangement of
collagen and hydration state of the cartilage will be
measured using T2 relaxation time mapping. Further-
more, knee cartilage morphology as a regional cartilage
thickness will be analysed from the weight bearing area
of tibiofemoral and patellofemoral cartilages. The
dGEMRIC method has been validated in several in vitro
studies [60-62] and it had been applied in several in vivo
studies [43,52,63-71]. Also, T2 relaxation time method
has been histologically validated in vitro [72], and it has
been applied in several human studies to assess chondral
repair [69,73-76].
MRI protocols
Prior to imaging, the subject will be advised to restrain
from any strenuous physical activity during the 48 hours
prior to the measurements to minimise possible transi-
ent changes in knee cartilage volume and composition.
Subjects will be imaged at the same time of the day
to avoid possible diurnal variation at the follow-upmeasurements. The participants will be imaged lying su-
pine with knee to be imaged in slight flexion, stabilized
in a leg holder and a custom made inflatable cushion.
The cushion has been specifically designed to stabilize
the patella without causing any compression of the
patellofemoral joint. The imaging session will last in
total 3 hours and will include initially a standard clinical
MRI series and T2 relaxation time followed by a
dGEMRIC series.
T2 mapping will be performed using a sagittal multi-
slice multi-echo fast spin echo sequence (field of view
(FOV) 140 mm, acquisition matrix 256 x 256, repeti-
tion time (TR) 2090 ms, eight echo times (TE) be-
tween 13 and 104 ms, echo train length (ETL) 8, slice
thickness 3 mm). The slices will be positioned perpen-
dicular to a line tangential to the posterior femoral
condyles in the axial scout view. Two slices, each cov-
ering the central region of the medial and lateral con-
dyles, will be analysed.
For the dGEMRIC series, immediately after the clinical
and T2 imaging a double dose of Gd-DTPA2- (Magnevist,
Schering, Berlin) will be administered intravenously i.e.,
0.4 ml/kg (0.2 mM/kg). At baseline, post intervention and
16 month follow up the amount of contrast administered
will be corrected for body weight. It is felt this is appropri-
ate because of the expected changes in body composition
as a result of the intensive exercise intervention. In order
to enhance the delivery of contrast agent into the knee
cartilage, following administration of Gd-DTPA2- the sub-
ject will be instructed to perform 5 minutes of flexion-
extension exercises in a sitting position without resistance,
5 minutes of walking on a flat surface and 10 gentle deep
squats. Exactly ninety minutes after the injection, T1 map-
ping in the presence of Gd-DTPA2- (dGEMRIC) will be
performed in the sagittal plane using a single slice inver-
sion recovery fast-spin echo sequence (FOV = 14 cm,
matrix 256 x 256, TR = 1800 ms, TE = 13 ms, six inversion
times (TI) between 50 and 1600 ms, slice thickness
3 mm). The slice positioning will be copied from the T2
relaxation time mapping sequence, and the number of the
slices in the correct orientation is reduced to one. The
remaining slice is then positioned at the centre of the
medial and lateral condyles as viewed on the axial
scout image. The subject will be positioned into an
identical position as for the first MRI imaging. For
both the MRI images and pQCT measurements the
knee with highest degree OA, as measured by the
radiographic Kellgren-Lawrence scale, will be imaged.
In the cases were both knee have identical KL score
the right knee will be imaged.
Segmentation
Weight bearing cartilage regions of interest (ROIs) from
single sagittal slices at the centre of the medial and
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using a semi-automated in-house MATLAB application
(Mathworks, Inc. Natick, MA, USA). dGEMRIC indices
will be corrected for BMI [77]. In this research team the
in vivo precision of dGEMRIC for full thickness cartilage
in different ROIs ranges from 5% to 7% [78]. The inter-
observer precision of T2 in different locations is on aver-
age 5% [79]. For quality assurance purposes, a set of
phantom samples containing certain concentrations of
agarose and nickel nitrate to modulate their T1 and T2
relaxation times will be imaged following the study
protocol prior to baseline and follow-up measurement
sessions to assess possible drift.Secondary outcomes
Properties of bone and body composition
Peripheral quantitative computed tomography (pQCT)
The bone properties of the distal radius and mid and
distal tibia will be measured using a pQCT device (XCT-
2000; Stratec Medizintechnik, Pforzhem, Germany). A
2-mm-thick single tomographic slice with pixel size
0.59 mm in plane resolution will be taken at 5% and
55% of the length of the tibia proximal to the distal end
of the tibia. Lower leg length is defined as the distance
between the medial condyle of tibia and medial malle-
olus. Selection of lower limb to be imaged will be based
on the same principles as the MRI scan. The forearm
slice will be taken at 4% of ulna length proximal to the
distal endplate of ulna. Length of ulna is defined as the
distance between olecranon process and the midline of
lateral aspect of distal ulna. In all cases right upper limb
will be scanned except when subjects had suffered from
fracture of either right ulna or radius. The analysis of
the pQCT images will be performed with the density dis-
tribution plug-in [80] of the BoneJ (http://bonej.org/
densitydistribution) [81] ImageJ (http://rsbweb.nih.gov/ij/
download.html) plug-in. Compressive bone strength index
(BSId, g
2/cm4), bone mineral content (BMC), total and tra-
becular density (ToD and TrD, mg/cm3) and total and tra-
becular area (ToA and TrA, mm2) will be analysed from
the shaft slices. The pQCT device is calibrated daily using
a standard phantom provided by the manufacturer and
coefficient of variation (CV) for these protocols in our la-
boratory has been measured to range between 1.5-3.4%
for the reported variables [82].
Dual-energy X-ray absorptiometry (DXA)
DXA (Lunar Prodigy; GE Lunar Healthcare, Madison, WI,
USA) will be used to assess body composition and bone
traits. Body composition analyses will be carried out using
enCORE software (ENcore 2011, version 13.60.033). Using
manufacturers software and protocols total body fat and
lean body mass will be measured. In vivo precision ofthese measurements has been reported to be CV 1.3-
2,2% [83]. Both proximal femur and Lumbar spine
(L2-4) areal bone mineral density (aBMD, g/cm2) and
bone mineral content (BMC, g) will be scanned. Cross
sectional geometry of the femoral neck will be analysed
using advanced hip structure analysis (AHA) as per
manufacturer’s software. This will include femoral neck
hip axis length (HAL, mm), cross sectional area (CSA,
mm2), cross sectional moment of inertia (CSMI, mm4)
and femoral neck strength index (FSI, mm3) [84-86].
In vivo repeatability, CV, of these methods has been
reported as 2.3% for CSA [87].Questionnaires
Health status General health and habitual physical ac-
tivity at baseline will be assessed by a questionnaire de-
vised by the research group. This health questionnaire
addresses medical conditions, current medications, years
of menopausal hormone therapy, history of fractures
and current leisure time physical activity. Throughout
the entire follow up period all subjects will be asked to
report their daily amount of analgesia taken to manage
their knee pain. Space will be provided in the physical
activity diary for ease of recording.Impact of osteoarthritis of the knee
Self-assessed impact of osteoarthritis on functioning will
be measured using two questionnaires, the Western
Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) [88] and the knee injury and osteoarthritis
outcome score (KOOS) [89]. The visual analogue version
(VAS) of the WOMAC (0-100 mm) will be used with a
range of scores of 0–2400. This questionnaire has 24
questions and is divided into three domains; pain (score
ranging from 0–500), stiffness (0–200) and function
(0–1700). A higher score indicates more disability. The in-
ternal consistence (Cronbach’s alpha) for the VAS version
is 0.7-0.91 and test-retest (ICC) coefficient is 0.95 for pain,
0.90 for stiffness and 0.92 for function ([90]). A likert
version of the KOOS will be used with each response be-
ing scored 0–4. The questionnaire has 5 domains: pain
(9 questions), other symptoms (7 questions), activities of
daily living (16 questions), sport and recreation (5 ques-
tions) and knee related quality of life (4 questions). Score
for global and domains scores are transformed into a
score 0–100 with a score of 0 indicating extreme knee
problems and 100 no knee problems. The internal
consistency for the KOOS is 0.86-0.96 and test-rest (ICC)
is (0.67-0.95) [91]. Reliability of the Finnish language ver-
sion of both WOMAC and KOOS has been shown to be
similar to that of the English language version [92].
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Self-assessed quality of life will be measured using the
RAND-36-Item short form healthy survey instrument
[93] this questionnaire is identical in wording to the
short form 36 questionnaire (SF-36) but summation of
final scores is different. It contains 8 domains: physical
functioning (10 items), role limitations due to physical
health problems (4 items), role limitations due to emo-
tional problems (3 items), energy/fatigue (4 items), emo-
tional well-being (5 items), social functioning (2 items),
pain (2 items), and general health (5 items). Global and
individual domains will be re-scored and given values of
0–100 with higher scores indicating a more favourable
health state. The scores will also be divided into two
summary measure: the physical component summary
score (PCS) and the mental component summary score
(MCS). The dimensions physical functioning, role limi-
tation due to physical health problems, body pain and
general health form the PCS and mental health, energy/
fatigue, social functioning and role limitations due to
emotional problems form the MCS. In a Finnish
standardization population sample aged 18–79 years
the homogeneity, i.e., the mean of the item inter-
correlations of the Scale, was 0.63 and Cronbach alpha
0.94 [94].Physical performance measures
Muscle strength Maximal isometric knee flexion and
extension strength of both legs, as well as grip strength
of dominant hand, will be measured using an adjustable
dynamometer chair (Good strength; Metitur Ltd,
Jyväskylä Finland). The best result from 3 contractions
will be used and recorded in newtons (N). In our la-
boratory, the precision of the test is 6% for knee exten-
sion and 9% for knee flexion [95].Muscle power
Single leg extension power will be measured using
Nottingham power rig (University of Nottingham
Medical School, Nottingham, UK) which has been
tested for reliability and has a test retest co-efficient of
variation (CV of 9.4%) [96] and in our laboratory the
CV is 8% [97].
In addition lower limb power function will be deter-
mined by a maximal counter movement jump (CMJ)
measured using a custom made force plate (University
of Jyväskylä, Finland). This test is a measure of neuro-
muscular function. Jumping force, vertical ground reac-
tion forces, power, impulse and jump height will be
calculated. Data is collected at a sampling frequency of
500 Hz [98].Aerobic fitness
Maximal aerobic power VO2 max will be estimated
using the UKK 2 km walk test (UKK Institute, Tampere,
Finland). This test requires the subject to walk 2 km as
quickly as possible with a target of 80% maximal heart
rate [99]. VO2 max is estimated using walking time,
body mass index (BMI), age and heart rate at end of test.
The heart rate will be measured by a portable heart-rate
monitor (Polar F6, Polar Electro Ltd, Kempele, Finland).
It is a feasible test for estimating V02 max [100] and
sensitive to changes [101]. Its validity has also been
tested with correlation coefficient of 0.69-0.77 [102].
Static balance
Static balance ability will be assessed using a force plat-
form device (Goodbalance, Metitur Ltd, Jyväskylä
Finland) which is validated and reliable method measur-
ing body sway in different standing positions [103,104].
Balance will be measured in feet side-by-side eyes open
and eyes closed and single leg stance [105].
Agility
Agility will be assessed with a standardised figure-of
-eight running test consisting of two laps around two
cones placed 10 meters apart in a figure of eight
[106-108]. Time (in seconds) taken to complete the task
will be measured using a photocell. This test has shown
to be effective at detecting decreased motor performance
(area under curve 0.86) additionally it has been shown
to be a very sensitive (73.5%) and specific (86.1%) tool
for measuring agility [109].
Gait
Spatial and temporal parameters of gait will be mea-
sured using the GAITRiteW walkway (CIR systems, inc.
Clifton, NJ 070872) [110]. This consists of a 577 cm
long and 88.5 cm wide matt with 13,824 sensors placed
on 1.27 cm in a grid. The collection frequency of the
matt is 80Hz. The data is transferred by lead to a com-
puter and is analysed using GAITRite 3.6b software.
This technique has been validated with different popu-
lations [111,112] and found to be a reliable [112,113]
instrument to measure spatial and temporal parameters
of gait.
Daily physical activity
During both the intervention period (0–4 months) and
the follow up period (5–16 months) daily physical activ-
ity of every subject (excluding pool training) will be
recorded using a leisure time physical activity diary. The
diary is completed daily and each activity, duration and
intensity (1 = low, 2 =moderate or 3 = hard) is recorded.
From this data MET-hours per week will be calculated
[114,115]. In addition, during the intervention period
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using a heart rate monitor (F6 Polar, Polar Oy, Finland),
accelerometers (Hookie AM 20, Traxmeet, Finland) and
hourly physical activity diaries.
Intervention
Those subjects randomised into the intervention group
will participate in 1 hour of aquatic resistance training,
three times a week for 4 months, totally 48 training ses-
sions. The intervention will be completed in small
groups of 6–8 subjects in a pool heated to 32 degrees
with depths 1.3-1.5 m. Aquatic steps will be used to en-
sure that all subjects will complete the standing exercises
at a depth level approximately to their xiphoid boneTable 1 Description of exercises included in the intervention
Warm-up (10-15 minutes) Str
1. Standing hip flexion/extension 1. Standing hip flexion
and stand on leg furth
forwards and backwar
Keep knee of moving
Maintain spinal neutra
2. Standing hip abduction/Abduction 2. Hip adduction/abdu
fully extended. Keepin
left leg from side to si
Left leg crosses over in
maintaining a neutral
3. Seated bilateral knee flexion/extension. 3. Seated knee flexion/
back of legs fixed agai
as fast as possible usin
4. Calf raises on edge of step (weeks 1-8 double
leg, weeks 9-16 single leg)
4. Standing knee flexio
and transfer weight on
wall straight up in fron
felt in the posterior as
knee as fast as possibl
5. Balance beam (EWAC, Netherlands) walking
forwards and backwards (weeks 1-6 without arms,
weeks 6-12 carry tray with ball on, 13-16 same
eyes closed)
5. Kickback (reverse lun
so that moving leg ca
with supporting leg in
flexion up near wall. L
bottom of pool and th
possible. During this m
aspect of foot is kept f
6. Standing abdominals (either pushing and pull
frisbee, trunk rotation with frisbee or rowing with
aquatic rolling pin), weeks 1-8 double leg stance,
week 9-16 single leg).
7. Abdominal with feet in frisbee against wall
(figure of 8, circles 30 second each direction)
8. Hurdles (EWAC Netherlands), weeks 1-6
stepping over hurdles, weeks 6-12 double leg
jumps forwards and backwards over 30 cm hurdle,
13-16 single leg jumps forwards over 30 cm high
hurdle)
9. Weeks 1-6 scissor jumps, weeks 6-12 jumping
over 30 cm hurdle sideways, weeks, 13-16 single
leg sideways jumping over 30 cm hurdle.
10. Dynamic balance ½ of the group jog/run
around other ½ of group who are trying to
maintain balance.±5 cm ensuring weight bearing on the supporting leg of
25-50% of own body weight [41].
Each training session will last approximately 1 hour.
The session will consist of three distinct parts; the warm-
up (15 minutes), lower limb strengthening program (35 -
minutes) and cool down (10 minutes), a full description of
exercises can be found from Table 1 and Figures 2, 3, 4, 5,
6. Warm up and cool down was planned by a physiother-
apist with over 10 years of aquatic therapy experience with
patients suffering from musculoskeletal problems (BW),
the same therapist will ensure that quality of movement
and intensity of the intervention is maintained throughout
the training by reviewing the heart rate and perceived ex-
ertion by BORG 6–20 scale [116] which are collected afterength training (35 minutes) Cool down
(10 minutes)
/extension (Figure 3): Standing side on to wall
est away from wall. Swing leg nearest wall
ds as fast as possible using full range of motion.
leg in full extension and ankle in dorsiflexion.
l at all times.
3-5 minutes of
walking and
supported cycling
against wall
ction (Figure 2): Stand on right leg with knee
g knee straight and ankle in dorsiflexion swing
de as fast as possible using full range of motion.
front of right leg. Particular attention is paid to
pelvic and spinal position.
Stretches, 30 seconds
stretch for each side.
extension (Figure 5): Sitting on chair keeping
nst seat, alternately flex and extend both knees
g full range of motion.
1. Hip flexors
(Iliopsoas)
n/extension (Figure 4): Standing side on to wall
to leg furthest away from wall. Lift leg nearest
t stopping just before any stretch sensation is
pect of thigh. Keeping thigh still, flex and extend
e using full range of motion.
2. Gluteus maximus
ge) (Figure 6): Standing on edge of step board
n be swung down next to it. Starting position is
full extend and other hip and knee is in
eg is explosively straightened down towards
en kicked backwards with leg straight as far as
ovement supporting leg is flexed but plantar
irmly pressed against step.
3. Quadriceps
4. Hamstrings
5. Iliotibial band
6. Adductors
7. Gastrocnemius
Figure 4 Knee flexion/extension in standing.Figure 2 Hip abduction/adduction in standing.
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http://www.biomedcentral.com/1471-2474/14/82every training session immediately after the main set be-
fore the cool down. All sessions will be supervised by 2
experienced physiotherapists, who had been trained to in-
struct these aquatic programmes and accredited for life-
saving before the trial began.
The warm-up consists of 10 different movements to
increase active ROM of all joints and enhance neuro-
muscular activation. Each movement will be completed
for 1 minute (30 seconds per leg when alternating leg)
with a 15 second rest period. Order of movements will
be altered for each session randomly to maximise neuro-
muscular stimulation and prevent staleness as well as to
maintain subjects’ interest.
The strength training section consists of 5 exercises
which have been thoroughly researched for both their ef-
fect on muscle activation [117,118] and effect on muscle
strength and physical functioning [119-121]. Focus will
be on performing each movement as fast as possible
through full ROM. During all standing exercises em-
phasis will be made on maintaining the lumbar spine inFigure 3 Hip flexion/extension in standing.a neutral position thus avoiding excessive loading on the
spine and to encourage activation of trunk muscles dur-
ing exercises. The progression of the exercise program
will be ensured by using resistance boots of different
sizes and by varying the duration of sets. Table 2 shows
the different durations of each set and targeted amount
of repetitions per set for each stage of the intervention.
Each leg will be trained before resting e.g. 45 seconds
left leg, 45 seconds right leg and 30 second rest.
Weeks 1–2 is an introductory period to allow subjects to
become familiar with the movements with sets of 45 -
seconds duration per leg per set with no resistance i.e.
barefoot. Weeks 3–5 will consist of alternate trainings of
30 or 45 seconds with small fins (THERABAND PROD-
UCTS, The Hygienic Corporation, Akron, OH 44310
USA). Weeks 6–8 will be 3 week period with 45 seconds of
work alternating sessions with small aquafins and large re-
sistance boots (Hydro-Tone hydro-boots, Hydro-Tone Fit-
ness Systems, Inc. Orange, CA 92865–2760, USA). Weeks
9–11 and 13–16 will consist of alternate trainings withFigure 5 Knee flexion/extension in sitting.
Figure 6 Kickback (reverse lunge).
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http://www.biomedcentral.com/1471-2474/14/82work of 30 and 45 seconds with large boots. Week 12 will
consist of one session barefooted, one with small fins and
one with large boots, work duration will be 45 seconds per
set. The frontal area of aquafin resistance fins is 0.0181 m2
and that of the large resistance boots 0.075 m2. In a previ-
ous study the drag experienced during seated aquatic knee
flexion/extension exercises in healthy women was triple
with the large boots compared to the barefoot condition.
Additionally, a significant increase in EMG activity was
seen with the large boots compared to no boots [117,122].
Intensity of training of every session will be monitored
using polar heart rate monitors (F6 or RCX5, Polar Oy,
Finland) and perceived rate of exertion (BORG 6–20)
[116]. Target training zone will be 60-80% of maximum
heart rate according to the Karvonen formula e.g. 60%
training limit = (220 – age) x 0.6 and 80% training limit =
(220 – age) x 0.8.
Blood lactate levels will also be measured so as to ob-
tain quantitative measures of training intensity and to
ensure all training groups have trained at similar inten-
sities. Samples will be taken during week 12, before
training after 15 minutes of rest and 3 minutes after ces-
sation of main strength training session. These will be
recorded for each different intensity level of training
(barefoot, small and large resistance boots, 45 secondsTable 2 Intensity and progression of each program for phase
Weeks Resistance
type
Sets Repetitions per
set
1-2 Barefoot 3 25-30
3-5 (alternating) Small 3 20-25
Small 3 12 to 15
6-8 and 12 Small/Large 3 14-20
9-11 and 13–16
(alternating)
Large 3 14-20
Large 3 12 to 15
*PRE = perceived rate of exertion (BORG 6–20).work per leg). Fingertip blood samples will be taken
using safety lancet, normal 21 G with penetration depth
1.8 mm (Sarstedt AG & co, Germany) and collected into
20 μL capillary tubes which are placed in 1-mL hemolyz-
ing solution. Care will be taken to clean skin to avoid
contamination from chlorinated pool water. Samples will
be analysed using an automatic system (EKF diagnostic,
Biosen, Germany) after training.
Control group
The control group will be asked to maintain normal
physical activity during the intervention period. They
will be offered two sham contact sessions consisting of
1 hour of light stretching and relaxation during the 4 -
month period.
Follow up period
After the post intervention measurements all partici-
pants will be advised to continue spontaneous physical
activity, no other specific instruction will be given to the
subject.
Ethical considerations
The study was given ethical consent on 30th November
2011 Dnro 19U/2011 from the Ethics Committee of the
Central Finland Health Care District. Written informed
consent will be obtained from all subjects before their
participation in the study. All subjects included have the
right to withdraw from the study whenever without
needing to provide a reason for withdrawal. The study
will be conducted according to good clinical and scien-
tific guidelines and the declaration of Helsinki (2000).
Assessment of side effects
Adverse effects or health problems attributable to the test-
ing protocol or interventions exercise protocol will be
documented and reported. Following each individual
measurement and training session self-reported knee pain
will be assessed using a visual analogue scale (VAS 0-
100 mm) along with any other physical symptoms such as
pain elsewhere than knee, stiffness and general fatigue. All
subjects will have medical insurance and have access to’s I-IV of aquatic exercises program
Time
(sec)
Recovery
(sec)
Target
PRE*
Total time
(mins)
Total No.
reps
45 30 14-15 30 750-900
45 30 15-16 30 600-750
30 45 16-17 26 288-360
45 30 16-17 30 420-600
45 30 16-18 30 420-600
30 45 16-18 26 288-360
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the 4 month intervention and 12 month follow up period.
Statistical analysis
All analyses will be based on both intention-to-treat and
dose related principles. Statistical analyses will be
performed using statistical software (Stata, release 12.1,
StataCorp, College Station, Texas and SPSS Version 19,
IBM Corporation).
Discussion
This paper describes the rationale and design of a
randomised control trial investigating the effect a pro-
gressive aquatic resistance training program will have on
patellofemoral and tibiofemoral cartilage, properties of
bone and body composition and physical function in
post-menopausal women with mild knee osteoarthritis.
Exercise is one of the main non-pharmaceutical treat-
ments recommended in the management of lower limb
OA [24-26,28,29]. It is presumed that training in an
aquatic environment has benefits for persons suffering
from lower limb OA, however exact content and inten-
sity of optimal training remain unclear [22]. For persons
with knee and/or hip OA there is strong evidence to
suggest aquatic exercise can cause a small but significant
reduction in pain [30,33,34,36,38,123-127], improves
self-assessed and measured function with a small to
moderate effect size [33-36,38,123-125,127-130]. In
addition, there is moderate evidence to show that
aquatic exercise can cause a small but significant im-
provement in aerobic fitness [33,35,127,129,131]. Further
there is limited data to suggest aquatic exercise can in-
crease lower limb strength [33-39] and improve balance
and decrease risk of falling [36,39,40]. Intensities of in-
terventions in previously studies may not have been high
enough to produce large changes in muscle strength and
cardiovascular fitness but reporting of exercise programs
used are in most cases incomplete. There are few studies
investigating the effect of a progressive resistance pro-
gram using specifically designed resistance equipment
to manage symptoms associated with knee OA even
though there is accumulating evidence to suggest it
can be effective in improving neuromuscular function
[117,118,120-122]. Also, there is some evidence to sug-
gest water based exercise can either maintain [132] or
slightly improve the properties of bone as measured with
DXA [133]. However these are of low quality evidence
and further research is required to validate the findings.
Both dGEMRIC [63,134] and T2 relaxation MRI
[7,72,135] can distinguish between normal and OA car-
tilage. These techniques have been shown to be sensitive
enough to demonstrate acute changes in human cartil-
age dGEMRIC [42,67] and T2-relaxation times [42,136].
These methods are therefore suitable for use in ourstudy, and it is known that correct biomechanical load-
ing of cartilage is important in maintaining cartilage
health whereas obesity and trauma are risk factors for
the development of OA [1]. Although there is evidence
to show that biochemical characteristics of cartilage can
be negatively affected with changes after periods of joint
immobilization [137,138] and non-weight bearing [136].
No evidence exists to show the impact of an intensive
non-impact exercise on cartilage.
As far as we know there have been no publications in-
vestigating the effect of aquatic exercise on cartilage and
properties of bone in persons with knee OA. The aim of
this study is to use repetitive aquatic resistance program
with high intensity and repetition to discover what ef-
fects non-impact training has on knee cartilage, proper-
ties of bone and physical function. The information
gained will help improve our understanding of the ef-
fects of exercise on the biochemical properties of cartil-
age and improve prescription of aquatic exercises in the
management of OA.
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